Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » Week in Review

Week in Review

Print

Summaries of each week's events in China biotech are provided free to all readers.  A weekly email newsletter providing direct links to these articles is also available - click here for free email newsletter...

Recent Articles

  Week in Review: China Life Science Venture Tie-up: WuXi and Frontline Merge
  Week in Review: Shanghai Pharma Considers $4 Billion Bid for Germany's Stada
  Week in Review: China Pharma Signs Cross-Border Deals
  Week in Review: Ping An Announces $1 Billion Fin-Tech/Healthcare VC Fund
  Week in Review: Cathay Fortune Pays $186 Million for German Diagnostic Company
  Week in Review: Tianjin CanSino Closes $65 Million Round for Vaccine Portfolio
  Week in Review: Dalian Wanda Plans $10 Billion Chengdu Healthcare Park
  Week in Review: Zai Lab Partners with GE on China Biologics Manufacturing
  Week in Review: Beijing's Creat Offers $1.3 Billion for Biotest of Germany
  Week in Review: BGI Genomics Plans $250 Million Shenzhen IPO
 
Login